| |
Alberta
|
British Columbia
|
Manitoba
|
New Brunswick
|
Newfoundland
|
Nova Scotia
|
Ontario
|
PEI
|
Quebec
|
Saskatchewan
|
|---|
|
Undiscounted lifetime cervical cancer cases
|
|
Vaccine A
|
223
|
71
|
23
|
8
|
6
|
11
|
269
|
2
|
208
|
11
|
|
Vaccine B
|
237
|
78
|
25
|
10
|
7
|
13
|
288
|
2
|
240
|
13
|
|
Difference (A- B)
|
−14
|
−8
|
−2
|
−2
|
−1
|
−2
|
−19
|
0
|
−32
|
−2
|
|
Undiscounted short-term budget impact (CAD)
|
|
Vaccine A
|
8 862 430
|
3 431 536
|
1 071 737
|
1 039 079
|
673 843
|
1 244 617
|
11 758 847
|
173 180
|
14 284 003
|
1 426 186
|
|
Vaccine B
|
8 862 430
|
3 431 536
|
1 071 737
|
1 039 079
|
673 843
|
1 244 617
|
11 758 847
|
173 180
|
14 284 003
|
1 426 186
|
|
Difference (A-B)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Discounted long-term budget impact (CAD)
|
|
Vaccine A
|
71 372 551
|
15 984 442
|
4 131 005
|
2 865 649
|
1 858 981
|
3 600 539
|
48 811 638
|
491 961
|
58 240 107
|
3 861 885
|
|
Vaccine B
|
72 015 197
|
16 091 773
|
4 155 215
|
2 890 712
|
1 874 203
|
3 630 560
|
49 128 834
|
495 873
|
58 720 943
|
3 894 102
|
|
Difference (A-B)
|
−642 645
|
−107 331
|
−24 210
|
−25 063
|
−15 222
|
−30 021
|
−317 196
|
−3 912
|
−480 836
|
−32 217
|
- Short-term budget impact: Considers 1 year of vaccine purchase and administration costs.
- Long-term budget impact: Considers lifetime costs to the health care system for the cohort of women eligible for vaccination in the 2011–12 school year. This includes both vaccinated and unvaccinated women.
- CAD - Canadian dollars.
- Vaccine A: HPV-16/18 AS04-adjuvanted vaccine.
- Vaccine B: HPV-6/11/16/18 vaccine.
- PEI – Prince Edward Island.
